Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo

Neuroscience

Volumn 154, Issue 2, 2008, Pages 606-620

  Moses, D ^a,c   Drago, J ^a   Teper, Y ^a   Gantois, I ^a   Finkelstein, D I ^a,b   Horne, M K ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

Author keywords

dopaminergic; GFP; neurospheres; rescue; substantia nigra; transplantation

Indexed keywords

AMPHETAMINE; BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GREEN FLUORESCENT PROTEIN; NEUROTROPHIN 3; OXIDOPAMINE; PLEIOTROPHIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; GENE EXPRESSION; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; MESENCEPHALON; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMPHETAMINE; ANIMALS; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; DOPAMINE; FEMALE; HYDROXYDOPAMINES; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; MICE, INBRED C57BL; NEOSTRIATUM; NEURONS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; STEREOTYPED BEHAVIOR; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 46549086903     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.03.058     Document Type: Article

References (100)

1. Aboody K.S., Brown A., Rainov N.G., Bower K.A., Liu S., Yang W., Small J.E., Herrlinger U., Ourednik V., Black P.M., Breakefield X.O., and Snyder E.Y. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 97 (2000) 12846-12851
2. Ader M., Schachner M., and Bartsch U. Transplantation of neural precursor cells into the dysmyelinated CNS of mutant mice deficient in the myelin-associated glycoprotein and Fyn tyrosine kinase. Eur J Neurosci 14 (2001) 561-566
3. Ader M., Schachner M., and Bartsch U. Integration and differentiation of neural stem cells after transplantation into the dysmyelinated central nervous system of adult mice. Eur J Neurosci 20 (2004) 1205-1210
4. Akazawa C., Tsuzuki H., Nakamura Y., Sasaki Y., Ohsaki K., Nakamura S., Arakawa Y., and Kohsaka S. The upregulated expression of sonic hedgehog in motor neurons after rat facial nerve axotomy. J Neurosci 24 (2004) 7923-7930
5. Andres R.H., Huber A.W., Schlattner U., Perez-Bouza A., Krebs S.H., Seiler R.W., Wallimann T., and Widmer H.R. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue. Neuroscience 133 (2005) 701-713
6. Appel E., Kolman O., Kazimirsky G., Blumberg P.M., and Brodie C. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. Neuroreport 8 (1997) 3309-3312
7. Balin B.J., Clark E.A., Trojanowski J.Q., and Lee V.M. Neurofilament reassembly in vitro: biochemical, morphological and immuno-electron microscopic studies employing monoclonal antibodies to defined epitopes. Brain Res 556 (1991) 181-195
8. Barker R.A. Continuing trials of GDNF in Parkinson's disease. Lancet Neurol 5 (2006) 285-286
9. Benoit B.O., Savarese T., Joly M., Engstrom C.M., Pang L., Reilly J., Recht L.D., Ross A.H., and Quesenberry P.J. Neurotrophin channeling of neural progenitor cell differentiation. J Neurobiol 46 (2001) 265-280
10. Bjorklund A., Rosenblad C., Winkler C., and Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 4 (1997) 186-200
11. Bjorklund A., Stenevi U., Schmidt R.H., Dunnett S.B., and Gage F.H. Intracerebral grafting of neuronal cell suspensions. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol Scand 522 (1983) 9-18
12. Borlongan C.V., Stahl C.E., Fujisaki T., Sanberg P.R., and Watanabe S. Cyclosporine A-induced hyperactivity in rats: is it mediated by immunosuppression, neurotrophism, or both?. Cell Transplant 8 (1999) 153-159
13. Bowenkamp K.E., David D., Lapchak P.L., Henry M.A., Granholm A.C., Hoffer B.J., and Mahalik T.J. 6-Hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor. Exp Brain Res 111 (1996) 1-7
14. Bowenkamp K.E., Hoffman A.F., Gerhardt G.A., Henry M.A., Biddle P.T., Hoffer B.J., and Granholm A.C. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol 355 (1995) 479-489
15. Campos L.S. Neurospheres: insights into neural stem cell biology. J Neurosci Res 78 (2004) 761-769
16. Chadi G., Moller A., Rosen L., Janson A.M., Agnati L.A., Goldstein M., Ogren S.O., Pettersson R.F., and Fuxe K. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Exp Brain Res 97 (1993) 145-158
17. Ciliax B.J., Heilman C., Demchyshyn L.L., Pristupa Z.B., Ince E., Hersch S.M., Niznik H.B., and Levey A.I. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15 (1995) 1714-1723
18. Clark E.A., and Lee V.M. Dynamics of mammalian high-molecular-weight neurofilament subunit phosphorylation in cultured rat sympathetic neurons. J Neurosci Res 30 (1991) 116-123
19. Curran E.J., Albin R.L., and Becker J.B. Adrenal medulla grafts in the hemiparkinsonian rat: profile of behavioral recovery predicts restoration of the symmetry between the two striata in measures of pre- and postsynaptic dopamine function. J Neurosci 13 (1993) 3864-3877
20. Deleyrolle L., Marchal-Victorion S., Dromard C., Fritz V., Saunier M., Sabourin J.C., Tran Van Ba C., Privat A., and Hugnot J.P. Exogenous and fibroblast growth factor 2/epidermal growth factor-regulated endogenous cytokines regulate neural precursor cell growth and differentiation. Stem Cells 24 (2006) 748-762
21. Donaldson A.E., Marshall C.E., Yang M., Suon S., and Iacovitti L. Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture. Mol Cell Neurosci 30 (2005) 601-610
22. Draberova E., Lukas Z., Ivanyi D., Viklicky V., and Draber P. Expression of class III beta-tubulin in normal and neoplastic human tissues. Histochem Cell Biol 109 (1998) 231-239
23. Drago J., Murphy M., Bailey K.A., and Bartlett P.F. A method for the isolation of purified murine neuroepithelial cells from the developing mouse brain. J Neurosci Methods 37 (1991) 251-256
24. Dunnett S.B., and Björklund A. Neural transplantation: a practical approach (1992), IRL Press, Oxford University Press, New York
25. Engele J., and Bohn M.C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J Neurosci 11 (1991) 3070-3078
26. Engele J., Rieck H., Choi-Lundberg D., and Bohn M.C. Evidence for a novel neurotrophic factor for dopaminergic neurons secreted from mesencephalic glial cell lines. J Neurosci Res 43 (1996) 576-586
27. Engele J., Schubert D., and Bohn M.C. Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia. J Neurosci Res 30 (1991) 359-371
28. Finkelstein D., Parish C.L., Stanic D., Borrelli E., Drago J., and Horne M.K. The role of dopamine receptors in regulating the size of axonal arbours. In: Nicholson L., and Faull R. (Eds). The international basal ganglia conference (2001), Kluwer Academic/Plenum Publishers, New York 313-322
29. Finkelstein D.I., Stanic D., Parish C.L., Tomas D., Dickson K., and Horne M.K. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience 97 (2000) 99-112
30. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates (1997), Academic Press, San Diego
31. Freed C., Revay R., Vaughan R.A., Kriek E., Grant S., Uhl G.R., and Kuhar M.J. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359 (1995) 340-349
32. Freeman T.B., Sanberg P.R., Nauert G.M., Boss B.D., Spector D., Olanow C.W., and Kordower J.H. The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant 4 (1995) 141-154
33. Friehs G.M., Parker R.G., He L.S., Haines S.J., Turner D.A., and Ebner T.J. Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism. J Neural Transplant Plast 2 (1991) 141-156
34. Frim D.M., Uhler T.A., Galpern W.R., Beal M.F., Breakefield X.O., and Isacson O. Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci U S A 91 (1994) 5104-5108
35. Goggi J., Theofilopoulos S., Riaz S.S., Jauniaux E., Stern G.M., and Bradford H.F. The neuronal survival effects of rasagiline and deprenyl on fetal human and rat ventral mesencephalic neurones in culture. Neuroreport 11 (2000) 3937-3941
36. Hagg T. Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo. Exp Neurol 149 (1998) 183-192
37. Hermann A., Maisel M., Wegner F., Liebau S., Kim D.W., Gerlach M., Schwarz J., Kim K.S., and Storch A. Multipotent neural stem cells from the adult tegmentum with dopaminergic potential develop essential properties of functional neurons. Stem Cells 24 (2006) 949-964
38. Hida H., Jung C.G., Wu C.Z., Kim H.J., Kodama Y., Masuda T., and Nishino H. Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur J Neurosci 17 (2003) 2127-2134
39. Ho A., and Blum M. Regulation of astroglial-derived dopaminergic neurotrophic factors by interleukin-1 beta in the striatum of young and middle-aged mice. Exp Neurol 148 (1997) 348-359
40. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.F., and Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci Lett 182 (1994) 107-111
41. Hornykiewicz O. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv Neurol 60 (1993) 140-147
42. Hornykiewicz O. Dopamine and Parkinson's disease. A personal view of the past, the present, and the future. Adv Neurol 86 (2001) 1-11
43. Hudson J.L., van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., Hoffer B.J., and Gerhardt G.A. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 626 (1993) 167-174
44. Hughes A.J., Daniel S.E., Blankson S., and Lees A.J. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50 (1993) 140-148
45. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., and Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350 (1991) 230-232
46. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., and Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 14 (1994) 335-347
47. Imitola J., Park K.I., Teng Y.D., Nisim S., Lachyankar M., Ourednik J., Mueller F.J., Yiou R., Atala A., Sidman R.L., Tuszynski M., Khoury S.J., and Snyder E.Y. Stem cells: cross-talk and developmental programs. Philos Trans R Soc Lond B Biol Sci 359 (2004) 823-837
48. Jensen J.B., Bjorklund A., and Parmar M. Striatal neuron differentiation from neurosphere-expanded progenitors depends on Gsh2 expression. J Neurosci 24 (2004) 6958-6967
49. Jeon B.S., Jackson-Lewis V., and Burke R.E. 6-Hydroxydopamine lesion of the rat substantia nigra: time course and morphology of cell death. Neurodegeneration 4 (1995) 131-137
50. Jin K., Mao X.O., Sun Y., Xie L., and Greenberg D.A. Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest 110 (2002) 311-319
51. Kaminska B., Gaweda-Walerych K., and Zawadzka M. Molecular mechanisms of neuroprotective action of immunosuppressants-facts and hypotheses. J Cell Mol Med 8 (2004) 45-58
52. Kirik D., Georgievska B., Rosenblad C., and Bjorklund A. Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. Eur J Neurosci 13 (2001) 1589-1599
53. Lang A.E., and Lozano A.M. Parkinson's disease. First of two parts. N Engl J Med 339 (1998) 1044-1053
54. Lang A.E., and Lozano A.M. Parkinson's disease. Second of two parts. N Engl J Med 339 (1998) 1130-1143
55. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., and Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993) 1130-1132
56. Lindholm P., Voutilainen M.H., Lauren J., Peranen J., Leppanen V.M., Andressoo J.O., Lindahl M., Janhunen S., Kalkkinen N., Timmusk T., Tuominen R.K., and Saarma M. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature 448 (2007) 73-77
57. Ling Z.D., Potter E.D., Lipton J.W., and Carvey P.M. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 149 (1998) 411-423
58. Ljungdahl A., Hokfelt T., Jonsson G., and Sachs C. Autoradiographic demonstration of uptake and accumulation of 3H-6-hydroxydopamine in adrenergic nerves. Experientia 27 (1971) 297-299
59. Martino G., and Pluchino S. The therapeutic potential of neural stem cells. Nat Rev 7 (2006) 395-406
60. Meissner K.K., Kirkham D.L., and Doering L.C. Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's. Brain Res 1057 (2005) 105-112
61. Mizumoto H., Mizumoto K., Shatos M.A., Klassen H., and Young M.J. Retinal transplantation of neural progenitor cells derived from the brain of GFP transgenic mice. Vision Res 43 (2003) 1699-1708
62. Moses D., Teper Y., Gantois I., Finkelstein D.I., Horne M.K., and Drago J. Murine embryonic EGF-responsive ventral mesencephalic neurospheres display distinct regional specification and promote survival of dopaminergic neurons. Exp Neurol 199 (2006) 209-221
63. Murase S., and McKay R.D. A specific survival response in dopamine neurons at most risk in Parkinson's disease. J Neurosci 26 (2006) 9750-9760
64. Okabe M., Ikawa M., Kominami K., Nakanishi T., and Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett 407 (1997) 313-319
65. O'Malley E.K., Sieber B.A., Black I.B., and Dreyfus C.F. Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture. Brain Res 582 (1992) 65-70
66. O'Malley E.K., Sieber B.A., Morrison R.S., Black I.B., and Dreyfus C.F. Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor. Brain Res 647 (1994) 83-90
67. O'Rourke D.A., Sakurai H., Spokes K., Kjelsberg C., Takahashi M., Nigam S., and Cantley L. Expression of c-ret promotes morphogenesis and cell survival in mlMCD-3 cells. Am J Physiol 276 (1999) F581-F588
68. Ostenfeld T., Horn P., Aardal C., Orpen I., Caldwell M.A., and Svendsen C.N. Mouse epidermal growth factor-responsive neural precursor cells increase the survival and functional capacity of embryonic rat dopamine neurons in vitro. Neuroreport 10 (1999) 1985-1992
69. Ostenfeld T., Joly E., Tai Y.T., Peters A., Caldwell M., Jauniaux E., and Svendsen C.N. Regional specification of rodent and human neurospheres. Brain Res 134 (2002) 43-55
70. Ourednik J., Ourednik V., Lynch W.P., Schachner M., and Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat Biotechnol 20 (2002) 1103-1110
71. Palmer M.R., Granholm A.C., van Horne C.G., Giardina K.E., Freund R.K., Moorhead J.W., and Gerhardt G.A. Intranigral transplantation of solid tissue ventral mesencephalon or striatal grafts induces behavioral recovery in 6-OHDA-lesioned rats. Brain Res 890 (2001) 86-99
72. Parish C.L., Finkelstein D.I., Drago J., Borrelli E., and Horne M.K. The role of dopamine receptors in regulating the size of axonal arbors. J Neurosci 21 (2001) 5147-5157
73. Parish C.L., Nunan J., Finkelstein D.I., McNamara F.N., Wong J.Y., Waddington J.L., Brown R.M., Lawrence A.J., Horne M.K., and Drago J. Mice lacking the alpha4 nicotinic receptor subunit fail to modulate dopaminergic neuronal arbors and possess impaired dopamine transporter function. Mol Pharmacol 68 (2005) 1376-1386
74. Park K.I., Ourednik J., Ourednik V., Taylor R.M., Aboody K.S., Auguste K.I., Lachyankar M.B., Redmond D.E., and Snyder E.Y. Global gene and cell replacement strategies via stem cells. Gene Ther 9 (2002) 613-624
75. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L., and Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422 (2003) 688-694
76. Rafuse V.F., Soundararajan P., Leopold C., and Robertson H.A. Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog. Neuroscience 131 (2005) 899-916
77. Rascol O., Goetz C., Koller W., Poewe W., and Sampaio C. Treatment interventions for Parkinson's disease: an evidence based assessment. Lancet 359 (2002) 1589-1598
78. Redmond Jr. D.E., Bjugstad K.B., Teng Y.D., Ourednik V., Ourednik J., Wakeman D.R., Parsons X.H., Gonzalez R., Blanchard B.C., Kim S.U., Gu Z., Lipton S.A., Markakis E.A., Roth R.H., Elsworth J.D., Sladek Jr. J.R., Sidman R.L., and Snyder E.Y. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A 104 (2007) 12175-12180
79. Reynolds B.A., and Rietze R.L. Neural stem cells and neurospheres-re-evaluating the relationship. Nat Methods 2 (2005) 333-336
80. Reynolds B.A., and Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255 (1992) 1707-1710
81. Richardson R.M., Broaddus W.C., Holloway K.L., and Fillmore H.L. Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline. Brain Res 1032 (2005) 11-22
82. Rosenblad C., Kirik D., and Bjorklund A. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Exp Neurol 161 (2000) 503-516
83. Rosenblad C., Martinez-Serrano A., and Bjorklund A. Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience 82 (1998) 129-137
84. Sanberg P.R. Neural stem cells for Parkinson's disease: to protect and repair. Proc Natl Acad Sci U S A 104 (2007) 11869-11870
85. Santa-Olalla J., Baizabal J.M., Fregoso M., del Carmen Cardenas M., and Covarrubias L. The in vivo positional identity gene expression code is not preserved in neural stem cells grown in culture. Eur J Neurosci 18 (2003) 1073-1084
86. Sawada H., Ibi M., Kihara T., Urushitani M., Honda K., Nakanishi M., Akaike A., and Shimohama S. Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J 14 (2000) 1202-1214
87. Schierle G.S., Leist M., Martinou J.C., Widner H., Nicotera P., and Brundin P. Differential effects of Bcl-2 overexpression on fibre outgrowth and survival of embryonic dopaminergic neurons in intracerebral transplants. Eur J Neurosci 11 (1999) 3073-3081
88. Stanic D., Finkelstein D.I., Bourke D.W., Drago J., and Horne M.K. Timecourse of striatal re-innervation following lesions of dopaminergic SNpc neurons of the rat. Eur J Neurosci 18 (2003) 1175-1188
89. Takeshima T., Johnston J.M., and Commissiong J.W. Mesencephalic type 1 astrocytes rescue dopaminergic neurons from death induced by serum deprivation. J Neurosci 14 (1994) 4769-4779
90. Temple S. The development of neural stem cells. Nature 414 (2001) 112-117
91. Toledo-Aral J.J., Mendez-Ferrer S., Pardal R., Echevarria M., and Lopez-Barneo J. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J Neurosci 23 (2003) 141-148
92. Tomac A., Widenfalk J., Lin L.F., Kohno T., Ebendal T., Hoffer B.J., and Olson L. Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc Natl Acad Sci U S A 92 (1995) 8274-8278
93. Uchida N., Buck D.W., He D., Reitsma M.J., Masek M., Phan T.V., Tsukamoto A.S., Gage F.H., and Weissman I.L. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97 (2000) 14720-14725
94. Ungerstedt U., Ljungberg T., and Steg G. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons. Adv Neurol 5 (1974) 421-426
95. Villadiego J., Mendez-Ferrer S., Valdes-Sanchez T., Silos-Santiago I., Farinas I., Lopez-Barneo J., and Toledo-Aral J.J. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J Neurosci 25 (2005) 4091-4098
96. Walkinshaw G., and Waters C.M. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Neuroscience 63 (1994) 975-987
97. Wang L., Muramatsu S., Lu Y., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Hanazono Y., Kume A., Urano F., Ichinose H., Nagatsu T., Nakano I., and Ozawa K. Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther 9 (2002) 381-389
98. West M.J., and Gundersen H.J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 296 (1990) 1-22
99. West M.J., Slomianka L., and Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231 (1991) 482-497
100. Zuch C.L., Nordstroem V.K., Briedrick L.A., Hoernig G.R., Granholm A.C., and Bickford P.C. Time course of degenerative alterations in nigral dopaminergic neurons following a 6-hydroxydopamine lesion. J Comp Neurol 427 (2000) 440-454